Lecanemab Homecare Service
University College London Hospitals NHS FT · Closed
- Buyer
- University College London Hospitals NHS FT
- Status
- Closed
- Country
- United Kingdom
- Region
- England
- Sector
- Professional Services
- Reference
- FaT-ocds-h6vhtk-04e3d2
- Published
- 2025-02-19
- Deadline
- 2025-03-26
Tender summary
Direct supply and administration of Lecanemab (Leqembi) in a patient’s home, via a homecare delivery service. Lecanemab is indicated for the treatment of mild cognitive impairment and mild dementia due to Alzheimer's disease in adult patients that are apolipoprotein E ε 4 (ApoE ε 4) heterozygotes or non-carriers. The service is being offered by UCLH private Healthcare and will be for private patients only.
This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.
Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.
Register for full access